#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Desmoplastic small round cell tumour Lymphangioma Anaemia Ataxia telangiectasia Gastroenteropancreatic neuroendocrine tumour disease Choroidal dystrophy Neonatal alloimmune thrombocytopenia Neuropathic arthropathy Superficial vein thrombosis Squamous cell carcinoma of the vulva Arterial tortuosity syndrome Mixed-type liposarcoma Angiosarcoma Infantile apnoea More trials…

    Learn about Rare Diseases

    Lymphangioma – Trials in Disease Mucous membrane pemphigoid – Diagnostics Progressive multifocal leukoencephalopathy – Life with Disease Mucopolysaccharidosis II Undifferentiated sarcoma – Trials in Disease Turner’s syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Wolfram syndrome Congenital generalised lipodystrophy – Basic Information Chronic granulomatous disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ascorbic Acid Bp Gozetotide Garetosmab Cytisinicline Brigatinib Vutrisiran Anastrozole Octocog Alfa Berzosertib SEPOFARSEN Bhv-7000 Ly4100511 Caplacizumab Acoramidis Timothy Grass Pollen Extract Namilumab Golimumab Hydroxypropyl Cellulose Lf Myrrh Colecalciferol More therapies…

    Learn about Your Condition

    Myocardial ischaemia Retinal vein occlusion Systemic candida Pulmonary venous thrombosis Endocarditis Ovarian epithelial cancer B-cell type acute leukaemia Electronic cigarette user Diabetic nephropathy Breast angiosarcoma Hypertrophic cardiomyopathy Salivary gland cancer Diabetes insipidus Metabolic surgery Sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Levetiracetam
    • Cyclophosphamide
    Italy

  • Study of 64Cu-DOTATATE and 18F-FDG PET/CT imaging to predict disease progression in patients with neuroendocrine neoplasms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma metastatic
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Copper (64Cu) Chloride
    • Fludeoxyglucose (18F)
    • Dotatate
    Denmark

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    Investigated Drugs:
    • Cefixime
    • Ciprofloxacin Hydrochloride
    • Fosfomycin
    Spain

  • Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Budesonide
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Iptacopan
    Czechia France Germany Greece Italy The Netherlands +1

  • Study on Personalized Maintenance Therapy with Rituximab and Corticosteroids for Patients with Pemphigus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pemphigus
    Investigated Drugs:
    • Rituximab
    France
Previous Page
1 … 346 347 348 349 350 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!